NASDAQ:MDVL - Nasdaq - US58406B2025 - Common Stock - Currency: USD
1.8
-1.23 (-40.59%)
The current stock price of MDVL is 1.8 USD. In the past month the price decreased by -51.22%. In the past year, price decreased by -89%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
WBA | WALGREENS BOOTS ALLIANCE INC | 3.72 | 8.78B | ||
GRDN | GUARDIAN PHRMCY SERVICES-A | N/A | 1.24B | ||
YI | 111 INC | N/A | 71.62M | ||
MGRX | MANGOCEUTICALS INC | N/A | 13.34M | ||
CJJD | CHINA JO-JO DRUGSTORES HOLDI | N/A | 8.53M |
MedAvail Holdings Inc is a US-based company operating in Consumer Staples Distribution & Retail industry. The company is headquartered in Phoenix, Arizona and currently employs 279 full-time employees. The company went IPO on 2008-10-20. MedAvail Holdings, Inc. is a pharmacy technology and services company. The firm is focused on developing and commercializing a self-service pharmacy, mobile application, and kiosk. Its core technology and product, the MedAvail MedCenter (the MedCenter), is a pharmacist-controlled, patient-interactive, prescription dispensing system akin to a pharmacy in a box. The company operates through two segments: Retail Pharmacy Services and Pharmacy Technology. The Retail Pharmacy Services segment operates as SpotRx, or the Pharmacy, which is a full-service retail pharmacy utilizing its automated pharmacy technology, primarily servicing Medicare patients in the United States. The Pharmacy Technology segment, through its MedAvail Technologies, Inc., develops and commercializes the MedCenter for direct sale or subscription to third-party customers, including some of the healthcare providers and systems, as well as large retail chains that provide full retail-pharmacy services using its technology.
MEDAVAIL HOLDINGS INC
4720 E Cotton Gin Loop, Suite 220
Phoenix ARIZONA L5N 5M4 US
CEO: Ed Kilroy
Employees: 279
Company Website: https://investors.medavail.com/overview/default.aspx
Phone: 18778300826
The current stock price of MDVL is 1.8 USD. The price decreased by -40.59% in the last trading session.
The exchange symbol of MEDAVAIL HOLDINGS INC is MDVL and it is listed on the Nasdaq exchange.
MDVL stock is listed on the Nasdaq exchange.
7 analysts have analysed MDVL and the average price target is 4.08 USD. This implies a price increase of 126.67% is expected in the next year compared to the current price of 1.8. Check the MEDAVAIL HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
MEDAVAIL HOLDINGS INC (MDVL) has a market capitalization of 2.90M USD. This makes MDVL a Nano Cap stock.
MEDAVAIL HOLDINGS INC (MDVL) currently has 279 employees.
MEDAVAIL HOLDINGS INC (MDVL) has a resistance level at 3.21. Check the full technical report for a detailed analysis of MDVL support and resistance levels.
The Revenue of MEDAVAIL HOLDINGS INC (MDVL) is expected to decline by -92.96% in the next year. Check the estimates tab for more information on the MDVL EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MDVL does not pay a dividend.
MEDAVAIL HOLDINGS INC (MDVL) will report earnings on 2024-04-11, after the market close.
MEDAVAIL HOLDINGS INC (MDVL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-43).
ChartMill assigns a fundamental rating of 3 / 10 to MDVL. The financial health of MDVL is average, but there are quite some concerns on its profitability.
Over the last trailing twelve months MDVL reported a non-GAAP Earnings per Share(EPS) of -43. The EPS decreased by -115.54% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -153.79% | ||
ROE | -199.57% | ||
Debt/Equity | 0.07 |
ChartMill assigns a Buy % Consensus number of 83% to MDVL. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 99.29% and a revenue growth -92.96% for MDVL